GROUP ONE TRADING, L.P. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464950. A total of 4 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$276,000
-59.7%
232,000
-39.0%
0.00%0.0%
Q2 2022$685,000
+59.7%
380,600
+79.0%
0.00%
Q1 2022$429,000
-39.3%
212,600
-18.5%
0.00%
-100.0%
Q4 2021$707,000
-39.3%
260,900
-0.0%
0.00%0.0%
Q3 2021$1,164,000
-29.3%
261,000
-8.0%
0.00%
-50.0%
Q2 2021$1,646,000
-75.4%
283,800
-70.2%
0.00%
-80.0%
Q1 2021$6,696,000
+61.0%
953,900
+10.1%
0.01%
+42.9%
Q4 2020$4,160,000
+136.4%
866,700
+187.1%
0.01%
+16.7%
Q3 2020$1,760,000
-38.9%
301,900
-29.3%
0.01%
-53.8%
Q2 2020$2,881,000
-9.6%
426,800
-14.8%
0.01%
-50.0%
Q1 2020$3,188,000
-4.4%
501,200
+56.7%
0.03%
+13.0%
Q4 2019$3,335,000
+97.6%
319,900
-25.5%
0.02%
+64.3%
Q3 2019$1,688,000
+892.9%
429,500
+3667.5%
0.01%
+600.0%
Q2 2019$170,000
-90.9%
11,400
-84.9%
0.00%
-90.5%
Q1 2019$1,876,000
+27.9%
75,600
-7.5%
0.02%
+61.5%
Q4 2018$1,467,000
+38.0%
81,700
+125.7%
0.01%
+62.5%
Q3 2018$1,063,000
-59.0%
36,200
-36.5%
0.01%
-63.6%
Q2 2018$2,592,000
-48.1%
57,000
-39.7%
0.02%
-56.0%
Q1 2018$4,990,000
-51.0%
94,500
-36.9%
0.05%
-30.6%
Q4 2017$10,186,000
-56.9%
149,800
-47.7%
0.07%
-66.4%
Q3 2017$23,608,000
-11.5%
286,500
+0.6%
0.21%
-22.7%
Q2 2017$26,666,000
+28.1%
284,800
-12.9%
0.28%
+14.5%
Q1 2017$20,820,000
+577.3%
327,000
+372.5%
0.24%
+706.7%
Q4 2016$3,074,000
+23.8%
69,200
+0.4%
0.03%
+11.1%
Q3 2016$2,484,000
+722.5%
68,900
+213.2%
0.03%
+575.0%
Q2 2016$302,000
-61.8%
22,000
-46.6%
0.00%
-63.6%
Q1 2016$791,000
-79.1%
41,200
-62.0%
0.01%
-75.6%
Q4 2015$3,791,000
-57.0%
108,300
+12.9%
0.04%
-63.1%
Q3 2015$8,819,000
+243.7%
95,900
+228.4%
0.12%
+238.9%
Q2 2015$2,566,000
+288.2%
29,200
+228.1%
0.04%
+260.0%
Q1 2015$661,000
-34.0%
8,900
-50.3%
0.01%
-33.3%
Q4 2014$1,002,000
-13.7%
17,900
-30.1%
0.02%
-16.7%
Q3 2014$1,161,000
-33.1%
25,600
-38.9%
0.02%
-33.3%
Q2 2014$1,735,000
+59.5%
41,900
+166.9%
0.03%
+50.0%
Q1 2014$1,088,000
-65.2%
15,700
-69.7%
0.02%
-61.7%
Q4 2013$3,128,000
+1017.1%
51,900
+1028.3%
0.05%
+840.0%
Q3 2013$280,0004,6000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Antara Capital LP 42,500$204,0000.04%
GROUP ONE TRADING, L.P. 866,700$4,160,0000.01%
JPMORGAN CHASE & CO 1,000,000$4,800,0000.00%
SIMPLEX TRADING, LLC 904$433,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLOVIS ONCOLOGY INC shareholders